BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: de Mattos ÂZ, Debes JD, Boonstra A, Yang JD, Balderramo DC, Sartori GDP, de Mattos AA. Current impact of viral hepatitis on liver cancer development: The challenge remains. World J Gastroenterol 2021; 27(24): 3556-3567 [PMID: 34239269 DOI: 10.3748/wjg.v27.i24.3556]
URL: https://www.wjgnet.com/1948-5182/full/v27/i24/3556.htm
Number Citing Articles
1
Sugan Panneerselvam, Cornelia Wilson, Prem Kumar, Dinu Abirami, Jayakrishna Pamarthi, Mettu Srinivas Reddy, Joy Varghese. Overview of hepatocellular carcinoma: from molecular aspects to future therapeutic optionsCell Adhesion & Migration 2023; 17(1): 1 doi: 10.1080/19336918.2023.2258539
2
Song Gao, Xingyue Jiang, Liang Wang, Shanshan Jiang, Hanyuan Luo, Yan Chen, Cheng Peng. The pathogenesis of liver cancer and the therapeutic potential of bioactive substancesFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1029601
3
Siqi Liu, Lanlan Yang, Shengnan Jia, Rui Zhao, Zhenjing Jin. Interleukin-35 suppresses the activity of natural killer-like B cells in patients with hepatocellular carcinomaInternational Immunopharmacology 2021; 100: 108161 doi: 10.1016/j.intimp.2021.108161
4
Yinghua Yuan, Xiaojin Yang, Desheng Xie. Role of hsa_circ_0066966 in proliferation and migration of hepatitis B virus‑related liver cancer cellsExperimental and Therapeutic Medicine 2021; 23(1) doi: 10.3892/etm.2021.11010
5
Luckshi Rajendran, Woo Jin Choi, Hala Muaddi, Tommy Ivanics, Jordan J. Feld, Marco P. A. W. Claasen, Matthew Castelo, Gonzalo Sapisochin. Association of Viral Hepatitis Status and Post-hepatectomy Outcomes in the Era of Direct-Acting AntiviralsAnnals of Surgical Oncology 2023; 30(5): 2793 doi: 10.1245/s10434-022-12937-8
6
Xiaoming Shi, Ni Li. Progress in China Epidemiology2022; : 215 doi: 10.1007/978-981-19-2199-5_10
7
Xuming Zhu, Hongxing Zhou. Neutrophil-to-Lymphocyte Ratio Can Distinguish Patients with Liver Cirrhosis from Healthy People but Cannot Distinguish Patients with Cirrhotic Hepatocellular Carcinoma from Patients with Liver CirrhosisJournal of Hepatocellular Carcinoma 2022; : 1127 doi: 10.2147/JHC.S387189
8
Monika Zajkowska, Barbara Mroczko. Chemokines in Primary Liver CancerInternational Journal of Molecular Sciences 2022; 23(16): 8846 doi: 10.3390/ijms23168846
9
Satomi Makiuchi, Ying Tian, Mao Fujimoto, Junko Kuramoto, Noboru Tsuda, Hidenori Ojima, Masahiro Gotoh, Nobuyoshi Hiraoka, Teruhiko Yoshida, Yae Kanai, Eri Arai. DNA methylation alterations of ADCY5, MICAL2, and PLEKHG2 during the developmental stage of cryptogenic hepatocellular carcinomaHepatology Research 2024; 54(3): 284 doi: 10.1111/hepr.13984
10
Sven H. Loosen, David Schöler, Mark Luedde, Johannes Eschrich, Tom Luedde, Karel Kostev, Christoph Roderburg. Differential role of chronic liver diseases on the incidence of cancer: a longitudinal analysis among 248,224 outpatients in GermanyJournal of Cancer Research and Clinical Oncology 2023; 149(7): 3081 doi: 10.1007/s00432-022-04198-5
11
Spencer Goble, Angelo Z. Mattos, Manuel Mendizabal, Jose D. Debes. Hepatitis C and hepatocellular carcinoma in Latin America: Elimination as a path to cancer preventionAnnals of Hepatology 2023; 28(6): 101149 doi: 10.1016/j.aohep.2023.101149